October 14, 2024 01:43 PM EDT
Deals
Pharma
Manufacturing

Eli Lil­ly re­veals £279M in­vest­ment in the UK through new gov­ern­ment deal

Anna Brown

News Reporter

Eli Lil­ly plans to in­vest £279 mil­lion ($364 mil­lion) in the UK as part of a new gov­ern­ment part­ner­ship in which the drug­mak­er will bring …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

No­var­tis ends mid-stage IPF tri­al, will keep test­ing drug in PAH

Pfiz­er de­tails re­sults from failed Phase 3 tri­al of Duchenne mus­cu­lar dy­s­tro­phy gene ther­a­py 

Up­dat­ed: Lund­beck makes $2.6B cash move for Long­board a month af­ter start­ing Phase 3 in Dravet syn­drome

Jasper shares ral­ly as chron­ic hives drug scores in small, ear­ly tri­al

Two GSK tri­als with long-act­ing drug in chron­ic rhi­nos­i­nusi­tis hit pri­ma­ry end­points

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times